Moses W. McMillan - Concepedia

Author

Moses W. McMillan

Also Known As

M. W. MCMILLAN, Moses W. McMillan

Publications

113

Citations

H-Index

Concepts

All Affiliations

Moses W. McMillan is an author at University of Illinois Urbana-Champaign specializing in drug discovery, medicinal chemistry, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	96
2	Natural Sciences	3	3	87
3	Biochemistry	3	3	87
4	Engineering	1	1	17
5	Biomolecular Engineering	1	1	17

Moses W. McMillan

Publications

113

Citations

H-Index

Page 1

	Year	Citations
Synthesis of the Selective D<sub>2</sub> Receptor Agonist PNU-95666E from <scp>d</scp>-Phenylalanine Using a Sequential Oxidative Cyclization Strategy Arthur G. Romero, W. H. DARLINGTON, Moses W. McMillan The Journal of Organic Chemistry Molecular PharmacologyMedicinal ChemistryDiversity Oriented SynthesisHeterocyclicBiochemistry	1997	52
Progress toward the Development of a Safe and Effective Agent for Treating Reentrant Cardiac Arrhythmias: Synthesis and Evaluation of Ibutilide Analogues with Enhanced Metabolic Stability and Diminished Proarrhythmic Potential Jackson B. Hester, John K. Gibson, Lewis V. Buchanan, Journal of Medicinal Chemistry Cardiac MusclePharmaceutical ScienceHeart FailureCardiac AnaesthesiaCardiovascular Pharmacology	2001	26
Synthesis of phenazine and phenoxazinone derivatives of geldanamycin as potential polymerase inhibitors Kenneth L. Rinehart, Moses W. McMillan, Thomas R. Witty, Bioorganic Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesAntimicrobial Chemotherapy	1977	18
Production Scale Synthesis of the Non-Nucleoside Reverse Transcriptase Inhibitor Atevirdine Mesylate (U-87,201E) William R. Perrault, K. Paul Shephard, Lori A. LaPean, Organic Process Research & Development EngineeringAtevirdine MesylateMolecular BiologyOrganic ChemistryAntiviral Drug	1997	17

Page 1